NCT05539963
A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 23, 2023
Completion: Dec 30, 2025